LOGIN  |  REGISTER
Astria Therapeutics
Assertio

InMode to Present at Upcoming Investor Conferences and Events

August 01, 2023 | Last Trade: US$17.88 0.03 -0.17

YOKNEAM, Israel, Aug. 1, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following investor conferences and events in August:

Canaccord Genuity's 43rd Annual Growth Conference

Presenters: Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer

Format: In-person fireside chat moderated by Kyle Rose, Senior Equity Analyst, and one-on-one meetings

Location: Boston, MA

When: Wednesday, Aug. 9 at 12:30 pm ET

A live webcast of the presentation can be accessed here.

Needham Virtual MedTech & Diagnostics 1x1 Conference

Presenters: Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer

Format: Virtual one-on-one meetings

When: Monday, Aug. 14

UBS Med Device Conference

Presenters: Yair Malca, Chief Financial Officer

Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Analyst, and one-on-one meetings

Location: Dana Point, CA

When: Tuesday, Aug. 15 at 9:00 am PT

A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
This email address is being protected from spambots. You need JavaScript enabled to view it.
917-607-8654

 

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB